Monte Rosa Therapeutics
BioTech/Drugs - Boston, MA, US
Monte Rosa Therapeutics Employees
Agustin Chicas
Director of Biology/ Head of Translational Drug Discovery (Boston)
Monte Rosa Therapeutics Senior Management
Monte Rosa Therapeutics Details
Small molecule protein degraders are set to reshape the way by which diseases will be treated. Our rational approach in targeting disease-causing proteins for degradation will deliver pioneering therapies for cancer and beyond. Headquartered in Boston with additional laboratory facilities in Basel, Monte Rosa Therapeutics is a private company launched in 2020. Initially seeded by Versant Ventures and incubated at Ridgeline Discovery in Basel, and The Institute of Cancer Research in London, Monte Rosa has raised $32.5 million from Versant and New Enterprise Associates. Academic co-founders are Prof. Raj Chopra and Prof. Ian Collins of The Institute for Cancer Research, UK.
Monte Rosa Therapeutics Technologies
Email Providers
Outlook
Customer Relationship Management
Salesforce
CMS
NetSuite
Domain Name Services
Route 53
Other
Microsoft Office 365